Skip to main content

Table 2 Genes to prioritise from protein-protein interaction analyses of SNPs and targets of myositis-specific antibodies (MSA) or myositis-associated autoantibodies (MAA)

From: Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies

All MSA/MAA targets (n = 28)

Subset of MSA/MAA targetsa (n = 21)

All SNPs (n = 22)

All SNPs (n = 22) and subsets of MSA/MAA targetsa (n = 21)

Gene

P corr value

Gene

P corr value

Gene

P corr value

Gene

P corr value

UBA2

3.03 × 10-4

GARS

3.16 × 10-4

UBE3B

8.03 × 10-4

TRAF6

3.01 × 10-4

GARS

5.05 × 10-4

PMS1

4.21 × 10-4

TRAF6

2.11 × 10-3

UBE3B

4.01 × 10-4

PMS1

3.63 × 10-3

UBA2

3.47 × 10-3

  

GARS

1.20 × 10-3

TRIM24

4.74 × 10-3

IARS

5.68 × 10-3

  

TARS

3.90 × 10-3

YARS

8.37 × 10-3

YARS

1.09 × 10-2

  

PSMD3

6.99 × 10-3

TRIM28

8.97 × 10-3

HARS

1.15 × 10-2

  

UBA2

1.19 × 10-2

NARS

9.17 × 10-3

AARS

1.78 × 10-2

  

PMS1

1.67 × 10-2

TRIM33

1.10 × 10-2

NARS

3.23 × 10-2

  

HSPA1B

2.73 × 10-2

IARS

1.15 × 10-2

    

YARS

3.79 × 10-2

MLH1

1.79 × 10-2

    

IARS

3.98 × 10-2

HARS

1.95 × 10-2

    

HARS

4.61 × 10-2

CHD3

2.67 × 10-2

    

HSPA1A

4.94 × 10-2

FARSA

3.02 × 10-2

      

AARS

3.10 × 10-2

      

TARS

3.23 × 10-2

      

EXOSC9

3.43 × 10-2

      

FARSB

4.61 × 10-2

      
  1. Listed in order of significance from most to least significant. P cor -values corrected for multiple testing. aSubset of autoantibody targets formed by selecting one protein from each complex.